81: Circulating tumour DNA testing in advanced EGFR positive NSCLC; a DGH experience of validation and clinical application of serum testing.
- Resource Type
- Article
- Source
Lung Cancer (01695002) . Jan2017 Supplement 1, Vol. 103, pS38-S38. 1p.- Subject
- *
NON-small-cell lung carcinoma
*CANCER treatment
*CIRCULATING tumor DNA
*EPIDERMAL growth factor receptors
*BLOOD serum analysis
*DIAGNOSIS - Language
- ISSN
- 0169-5002